Marker gets $1.6M NIH grant to further screening technology

03/15/2012 | GenomeWeb Daily News (free registration)

The NIH's National Institute of Neurological Disorders and Stroke awarded Marker Gene Technologies a Phase II small business innovation research grant to help advance its screening technology for lysosomal storage disease drugs. Marker will use the three-year grant worth $1.6 million to develop live cell and tissue tests for drug candidates.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA